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General Procedures 
Flash column chromatography was performed on Kiesegel 60 silica gel (230-240 mesh, 
EM Science).  Analytical thin-layer chromatography was performed using E. Merck 
silica gel Kiesegel 60 F254 (0.24 mm) plates.  Compounds were made visible by staining 
with a ninhydrin solution followed by heating.  Mass spectra were obtained on a Thermo 
Finnigan LTQ ESI-MS.  Solution of compounds in MeOH:H2O:AcOH (9:0.9:0.1) were 
introduced into the instrument by direct infusion.  Nuclear magnetic resonance spectra 
were recorded on a Bruker DPX-300 instrument using standard deuterated solvents. 
 
Stereochemical Resolution of 3 and 4 from 2 
The racemic mixture of N-Boc t-butyl esters of trifluoroleucine (TFL) could be easily 
separated into the two enantiomeric pairs 5a and 5b by flash column chromatography.  In 
addition, racemization at C2 allowed for recycling of the undesired 2R diastereomers 
(Scheme S1).  Assignment of absolute stereochemistry and corresponding 1H NMR 
spectra have been previously reported for compounds 3 and 4.1  Analytical data for new 
compounds are reported below. Procedures for all other compounds were adapted from 
literature.1 
 
N-Boc-5,5,5-TFL t-butyl esters (5a and 5b) 
TFL (2) was converted to the N-Boc derivative using literature procedures.2  N-Boc TFL 
(2.05 g, 7.03 mmol) was added to anhydrous t-BuOH (100 mL) maintained at 32 °C.  To 
this solution, (Boc)2O (1.73 g, 7.93 mmol) and DMAP (88 mg, 0.72 mmol) were added in 
that order.  The reaction was stirred under argon for 1 h.  The product was purified by 
flash chromatography using n-pentane/ methyl t-butyl ether (MTBE) (20:1) as the eluent 
to give 560 mg of 5a as a white solid and 561 mg of 5b as a pale yellow oil.  A mixture 
of diastereomers (162 mg) was also recovered, resulting in an overall yield of 52% from 
2. 
 
(2S,4S)-,(2R,4R)-N-Boc-5,5,5-trifluoroleucine t-butyl ester (5b) 
Rf: pentane/MTBE (5:1) 0.43; 1H NMR (300 MHz, CDCl3) δ 1.20-1.22 (d, 3H, J = 6.9 
Hz), 1.45 (s, 9H), 1.47 (s, 9H), 1.76-1.84 (dt, 2H, J = 3.9, 9.9 Hz), 2.2-2.4 (m, 1H), 4.24-
4.26 (m, 1H), 4.94-4.97 (d, 1H, J = 8.1 Hz); 13C NMR (75.5 MHz, CDCl3) δ 171.9, 
156.1, 130.4, 126.7, 82.89, 80.51, 51.72, 35.31 (q, 2JCF = 26.9 Hz), 33.42, 30.13, 28.68, 
28.36, 12.70; ESI-MS m/z 364.20 (100, [M+23]+), calculated for C15H26NO4F3 341.37. 
 
(2S,4R)-,(2R,4S)-N-Boc-5,5,5-trifluoroleucine t-butyl ester (5a) 
Rf: pentane/MTBE (5:1) 0.38; 1H NMR (300 MHz, CDCl3) δ 1.18-1.20 (d, 3H, J = 6.9 
Hz), 1.45 (s, 9H), 1.48 (s, 9H), 1.57-1.67 (m, 2H), 2.07-2.16 (m, 1H), 2.37-2.39 (m, 1H) 
4.20-4.22 (m, 1H), 5.10-5.14 (d, 1H, J = 6.0 Hz); 13C NMR (75.5 MHz, CDCl3) δ 171.5, 
155.5, 130.3, 126.6, 83.08, 80.43, 52.43, 35.45 (q, 2JCF = 26.2 Hz), 33.64, 30.12, 28.70, 
28.37, 13.36; ESI-MS: m/z 364.17 (100, [M+23]+), calcd for C15H26NO4F3 341.37. 
 
(2S,4R)-5,5,5-trifluoroleucine (4) 
To a solution of 5a (622 mg, 1.82 mmol) in 4 mL CH2Cl2 was added CF3CO2H (4 mL).  
The solution was stirred at room temperature for 1 h.  After removal of the solvent, the 
resulting residue was dissolved in 4 mL 1N HCl and extracted with 3 × 5 mL CH2Cl2.   
The solvent (water) was removed by rotary evaporation and freeze drying.  The 
corresponding TFL·HCl salt was obtained in 87% yield (352 mg).  A 5 mL aqueous 
solution of TFL·HCl (352 mg, 1.58 mmol) and NaOH (253 mg, 6.32 mmol) was cooled 
to 0 °C.  To this solution, Ac2O (224 µL, 2.37 mmol) was added dropwise.  The mixture 
was acidified to pH 2.5 with conc. HCl, and extracted with 3 × 100 ml EtOAc.  The 
combined organic layers were dried over MgSO4.  Rotary evaporation of the solvent 
yielded 6a as a white solid (314 mg, 88%). 
 
Compound 6a (314 mg, 1.38 mmol) was subjected to enzymatic resolution as previously 
described.  Compound 4b was recovered from the reaction (190 mg).  Compound 4 was 
obtained in 59% yield (71 mg). 
 
Compound 3 was obtained from 6b using the same procedures as above. 
 
Deacetylation and Racemization of (2R,4R)-N-Acetyl-5,5,5-trifluoroleucine (3b)3 
Compound 3b (113 mg, 0.49 mmol) was refluxed in 3N HCl for 3 hours.  The solvent 
was removed by rotary evaporation and lyophilization. The residue so obtained was 
dissolved in 25 mL of acetic acid to which 0.05 eq of benzaldehyde was added.  The 
reaction was stirred at 90 °C for 12 h.  The solvent was removed by rotary evaporation.  
The residue was dissolved in 25 mL 1N HCl, then extracted with 3 × 20 mL EtOAc. 
Removal of water delivered 2 in quantitative yield, and with C2 judged to be racemic by 
1H NMR. 
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Table 1S. Melting Transitions from CD 
Protein Tm (οC) 
Leu-A1 55 
SS-A1 65 
SR-A1 65 
SS-A1•SR-A1[a] 68 
[a]
 This sample is an equimolar mixture of 
SS-A1 and SR-A1.  A1 made from the SS-
SR isomer mixture 2 exhibited a Tm of  
67oC.4 
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